Free Trial

Viracta Therapeutics (VIRX) SEC Filings & 10K Form

Viracta Therapeutics logo
$0.02 0.00 (-0.79%)
As of 03/28/2025 03:50 PM Eastern

Recent Viracta Therapeutics SEC Filings

DateFilerForm TypeView
02/14/2025
7:25 PM
FORWARD VENTURES V LP (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
Form SCHEDULE 13G
02/05/2025
4:00 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
4:14 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2024
3:39 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:14 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:06 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:08 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:20 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:33 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
Form SC 13G/A
11/13/2024
6:30 AM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:46 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:10 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
5:13 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
6:15 AM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
6:47 PM
Murphy Samuel Lafayette (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:48 PM
Chung Jane (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:49 PM
Borellini Flavia (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:50 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:39 PM
Rubino Stephen (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:40 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:43 PM
Barlow Jane F (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:44 PM
Simon Barry J. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:46 PM
DARCY THOMAS E (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:46 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:07 PM
ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:12 PM
Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
4:04 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:15 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form ARS
04/09/2024
3:30 PM
Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:VIRX) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners